JAK2 and myeloproliferative neoplasm: Notably, in some MPN patients, JAK2 is expressed in fusion with a centrosomal protein PCM1 [48–50] and can reside at the centrosome with readily detectable kinase activity, which is likely to result from the dimerization of the centrosomal protein.